Xcene Laboratory and Diagnostics (XLD) is Catalyzing a New Era for African Research and Diagnostics! Every medical breakthrough, every lifesaving treatment, and every public health victory began with one invisible step: a test. A vial of blood. A strand of DNA. A microscopic

At ASCAT 2025, Xcene Research was honoured to share its journey in advancing sickle cell disease (SCD) clinical trials across Sub-Saharan Africa. Our Executive Director, Adebukunola Telufusi, represented by Uchechukwu Nwaoha, a Senior Clinical Trial Associate at Xcene Research,

Across Africa, the healthcare and laboratory ecosystem continues to face significant challenges, including limited access to advanced diagnostic infrastructure, long sample turnaround times, and dependence on foreign laboratories for complex testing and clinical research support.

Africa holds 16% of the world’s population, yet contributes less than 3% of global clinical trials. This gap limits access to innovative therapies, delays medical breakthroughs, and leaves much of Africa’s unique health data untapped. At XCENE RESEARCH, we’re bridging that

XCENE RESEARCH VIRTUAL CAREER FAIR 2025 Explore. Connect. Grow. At Xcene Research, we are committed to building the next generation of #ClinicalResearch Professionals, shaping and impacting healthcare outcomes across Sub-Saharan Africa. Are you passionate about advancing

#Oncology burden in Nigeria and across Africa remains substantial, with high incidence and mortality from common cancers and challenges such as late-stage presentation and limited access to affordable therapies. Breast cancer is the most frequently diagnosed cancer among women in

Empowering women in healthcare drives discoveries that transform lives and shape the future. When we enable women to lead, innovate, and thrive in science, research, and healthcare, everyone gains. Today, we celebrate the brilliant women at Xcene Research and across the global

Our CEO, Adebukunola Telufusi, recently met with the Honorable Minister for Health and Social Welfare, Dr. Iziaq Adekunle Salako, to reflect on Xcene Research’s decade-long impact as a Clinical Research Organization (CRO) and to outline our strategic roadmap for the next 10